Answers are grounded in this paper and cite their sources.
Background Hereditary transthyretin cardiac amyloidosis (ATTRv-CA) has a long latency phase before clinical onset, creating a need to identify subclinical disease. We hypothesized circulating transthyretin (TTR) and retinol binding protein 4 (RBP4) levels would be associated with TTR carrier status and correlated with possible evidence of subclinical ATTRv-CA.
No takes yet. Share an insight, caveat, or question.
Hendren et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: